Global indices are mixed ahead of the U.S. non-farm payrolls report for April as many centers return to work after the May Day public holiday. AstraZeneca investors appear under-whelmed after the first Pfizer sweetener to an indicative offer initially proposed in early January. The Viagra maker is now offering about $106 billion for the British drugs group¿s stock and is lobbying U.K. politicians including PM Cameron furiously to win their approval.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
